• info@steminsights.org

Triomics raises $15M Series A to automate cancer clinical trials matching


For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each year, only 3% to 5% of eligible patients enroll in investigations of new treatments. Triomics, a generative AI startup, claims it can significantly reduce the time it takes doctors to match […]

© 2024 TechCrunch. All rights reserved. For personal use only.



Leave a Reply

Your email address will not be published. Required fields are marked *